Sign In
Buy MNLO
$0.555
+0 (+0%)
At Close: Aug 17, 2022
Menlo Therapeutics to Present at the Jefferies Virtual Healthcare Conference
12:00pm, Tuesday, 26'th May 2020
BRIDGEWATER, N.J., May 26, 2020 -- Menlo Therapeutics Inc. (Nasdaq: MNLO) (“Menlo” or the “Company”), a specialty pharmaceutical company focused on developing and.
Robbins Geller Rudman & Dowd LLP Announce Proposed Settlement in the Menlo Therapeutics Inc. Securities Settlement
12:30pm, Friday, 22'nd May 2020
Robbins Geller Rudman & Dowd LLP Announce Proposed Settlement in the Menlo Therapeutics Inc. Securities Settlement
Menlo Therapeutics is a Must-Watch Ahead of June PDUFA Date, Says Analyst
12:27am, Wednesday, 20'th May 2020
Out on the Street, small-cap biotechs have taken center stage. Those racing to develop a COVID-19 vaccine or treatment have been thrust into the spotlight, receiving a standing ovation in the form of
Xencor Reports Initial Dose-Escalation Data from Phase 1 Study of XmAb®20717, PD-1 x CTLA-4 Bispecific Antibody, in Solid Tumors
12:00am, Wednesday, 13'th May 2020
Xencor, Inc. (NASDAQ:XNCR), a clinical-stage biopharmaceutical company developing engineered monoclonal antibodies for the treatment of cancer and aut
Menlo Therapeutics' (MNLO) CEO Dave Domzalski on Q1 2020 Results - Earnings Call Transcript
06:30pm, Monday, 11'th May 2020
Menlo Therapeutics Inc. (NASDAQ:MNLO) Q1 2020 Earnings Conference Call May 11, 2020 8:30 AM ET Company Participants Michael Wood – LifeSci Advisors Dave Domzals
Puma's (PBYI) Earnings and Revenues Beat Estimates in Q1
04:01pm, Monday, 11'th May 2020
Puma Biotech's (PBYI) loss and revenues better estimates in the first quarter of 2020.
Menlo Therapeutics Inc (MNLO) Reports Q1 Loss, Lags Revenue Estimates
01:05pm, Monday, 11'th May 2020
Menlo Therapeutics Inc (MNLO) delivered earnings and revenue surprises of -90.00% and -20.64%, respectively, for the quarter ended March 2020. Do the numbers hold clues to what lies ahead for the stoc
Menlo Reports First Quarter 2020 Financial Results and Provides Business Update
11:00am, Monday, 11'th May 2020
Conference Call Today at 8:30am Eastern Time BRIDGEWATER, N.J., May 11, 2020 -- Menlo Therapeutics Inc. (Nasdaq: MNLO) (“Menlo” or the.
Horizon Therapeutics' (HZNP) Q1 Earnings Beat Estimates
12:00am, Thursday, 07'th May 2020
Stocks Analysis by Zacks Investment Research covering: Vertex Pharmaceuticals Inc, Horizon Pharma PLC, Abeona Therapeutics Inc, Menlo Therapeutics Inc. Read Zacks Investment Research's latest article
Menlo Therapeutics Inc. (MNLO) Shares March Higher, Can It Continue?
01:32pm, Wednesday, 06'th May 2020
As of late, it has definitely been a great time to be an investor in Menlo Therapeutics Inc. (MNLO).
Menlo Therapeutics to Report First Quarter 2020 Financial Results on May 11
12:00pm, Tuesday, 05'th May 2020
BRIDGEWATER, N.J., May 05, 2020 -- Menlo Therapeutics Inc. (Nasdaq: MNLO) (“Menlo” or the “Company”), a specialty pharmaceutical company focused on developing and.
Agios' (AGIO) Q1 Loss Narrower Than Expected, Revenues Beat
01:57pm, Friday, 01'st May 2020
Agios' (AGIO) loss and revenues better estimates in Q1. The company's wholly owned leukemia drug Tibsovo sees a sequential rise in sales.
Blueprint Medicines (NASDAQ:BPMC) and Menlo Therapeutics (NASDAQ:MNLO) Head-To-Head Review
06:22am, Monday, 27'th Apr 2020
Blueprint Medicines (NASDAQ:BPMC) and Menlo Therapeutics (NASDAQ:MNLO) are both medical companies, but which is the superior business? We will compare the two businesses based on the strength of their
3 Biotech Stocks Under $4 With Big Upside Potential
11:51am, Sunday, 26'th Apr 2020
At the very moment it looked like the market was down for the count, stocks bounced back. After being dealt hefty blows earlier in the week due to the record-breaking drop in oil prices, all three of
Menlo (MNLO) in Focus: Stock Moves 9.9% Higher
12:53pm, Friday, 24'th Apr 2020
Menlo (MNLO) saw a big move last session, as its shares jumped nearly 10% on the day, amid huge volumes.
